BioCentury | May 21, 2015
Translation in Brief

Formula's Italian CAR

...Formula Pharmaceuticals Inc. has licensed a chimeric antigen receptor (CAR) technology from Fondazione Matilde Tettamanti Menotti De Marchi Onlus that it thinks...
BioCentury | May 18, 2015
Company News

Fondazione Tettamanti, Formula Pharmaceuticals deal

...testing in 2016. Formula declined to provide financial terms, and Fondazione Tettamanti could not be reached. Fondazione Matilde Tettamanti Menotti De Marchi Onlus...
Items per page:
1 - 2 of 2
BioCentury | May 21, 2015
Translation in Brief

Formula's Italian CAR

...Formula Pharmaceuticals Inc. has licensed a chimeric antigen receptor (CAR) technology from Fondazione Matilde Tettamanti Menotti De Marchi Onlus that it thinks...
BioCentury | May 18, 2015
Company News

Fondazione Tettamanti, Formula Pharmaceuticals deal

...testing in 2016. Formula declined to provide financial terms, and Fondazione Tettamanti could not be reached. Fondazione Matilde Tettamanti Menotti De Marchi Onlus...
Items per page:
1 - 2 of 2